Michael R. McKellar, BA
Advertisement
Articles by Michael R. McKellar, BA
This commentary discusses why antibiotics and the treatment of infectious diseases present a special case for pharmaceutical development, pricing, and appropriate utilization.
Advertisement
Latest Updated Articles
- The Economics of Resistant Pathogens and Antibiotic Innovation
Published: April 23rd 2014 | Updated:
- The Economics of Resistant Pathogens and Antibiotic Innovation
Published: March 18th 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
3
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
4
Exploring Identity, Appearance Experiences Among Patients With Alopecia
5
